Ditto Bio Analysis
What is Ditto Bio?
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. The company says its AI platform identifies proteins with therapeutic potential and has found thousands of candidate proteins. Its site highlights a research program spanning rheumatoid arthritis, eczema, inflammatory bowel disease, psoriasis, lupus, asthma, Crohn's disease, multiple sclerosis, type 1 diabetes, autoimmune kidney disease, ulcerative colitis, celiac disease, vitiligo, Hashimoto's disease, Graves' disease, and inflammation.
Location
San Francisco, United States
Employees
1-10
Founded
2025
Industry
Healthcare, Drug Discovery And Delivery
Business Model v4
Biotech
Delivery Model
Developer platform / API / infra
YC Batch
W26
YC Partner
Ankit Gupta
Who are the founders of Ditto Bio
DS
Dennis Sun
Cofounder at Ditto Bio (YC W26)
AB
Adair Borges
Cofounder at Ditto Bio (YC W26)
Product Description
Ditto Bio specializes in discovering drugs for autoimmune diseases by utilizing proteins derived from parasites. Their main product offering is an AI platform designed for protein identification, which aids in drug discovery specifically targeting autoimmune conditions such as rheumatoid arthritis and multiple sclerosis.
Key features of Ditto Bio's offerings include:
- AI-Driven Protein Identification: The platform leverages artificial intelligence to identify proteins that can modulate the immune system, which is crucial for developing new therapeutic options.
- Natural Compound Utilization: The company emphasizes that "the best drugs come from nature," focusing on harnessing natural compounds from parasites for therapeutic applications.
- Targeted Drug Discovery: Their research is specifically aimed at addressing diseases characterized by an overactive immune response, providing a focused approach to drug development.
The benefits of Ditto Bio's offerings include the potential for innovative treatments for autoimmune diseases, which are often challenging to manage with existing therapies. By exploring the unique properties of parasite proteins, Ditto Bio aims to create more effective and targeted therapies for patients suffering from these conditions.
See something that needs updating? Suggest edits to this profile.